In this Review:
Anti-PD-L1 in ART-treated HIV-1 infection
Long-acting HIV inhibitor with multiple modes of action
MK-8591 for HIV
Long-acting maintenance with cabotegravir + rilpivirine
Long-term safety of TAF in renal impairment
BMD recovery after stopping PrEP
Long-acting cabotegravir: tolerability, pharmacokinetics and acceptability
Dapivirine vaginal rings for HIV-1 prevention in African women
Early ART and CV disease risk in START participants
Quadrivalent HPV vaccine in older HIV-positive adults
Please login below to download this issue (PDF)